Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IBA is a Belgian publicly traded healthcare technology company best known for proton therapy systems, dosimetry solutions, and equipment and services used in the production of radiopharmaceuticals. The company describes itself as a world leader in particle accelerator technology, with core activities spanning Proton Therapy, Dosimetry, RadioPharma Solutions, and Industrial Solutions. In healthcare, IBA supplies Proteus proton therapy systems, quality-assurance and dosimetry products, and cyclotron and PET-center solutions that support nuclear medicine and radiopharmaceutical production. Rather than operating as a therapeutics developer with a conventional drug pipeline, IBA primarily commercializes capital equipment, software, consumables, and related services for oncology and nuclear medicine customers. The group is headquartered in Louvain-la-Neuve, Belgium and has a global footprint with more than 2,000 employees.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IBA Group.